San Diego, CA, United States of America

Prognosys Biosciences, Inc.

Calculating rank
USPTO Granted Patents = 75


Forward Citations = 5,902

Loading Chart...
Loading Chart...

5 inventors (with patents filed for the assignee):

goldMedal Mark S Chee (73 out of 188 patents)

silverMedal David A Routenberg (14 out of 14 patents)

bronzeMedal John Andrew Altin (4 out of 4 patents)

4.  Igor A Kozlov (3 out of 15 patents)

5.  Petr Capek (3 out of 8 patents)

6.  David Routenberg (5 patents)


Core Competencies:
Biological Assays
Spatial Encoding
Peptide Detection
Nucleic Acid Constructs
Microfluidic Devices
MHC Binding
Polynucleotide Conjugates
Sample Imaging
Molecular Arrays
Target Analysis
Biological Targets
Assay Systems

75 patents:

Company Overview
Prognosys Biosciences, Inc. is a San Diego-based company specializing in advanced biological assays. The organization focuses on innovative technologies such as spatial encoding and peptide detection, which enhance the analysis of biological samples. Their expertise extends to nucleic acid constructs and microfluidic devices, facilitating precise MHC binding and polynucleotide conjugation. By integrating cutting-edge sample imaging techniques, Prognosys aims to advance research and diagnostics in the life sciences sector.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

75 Patents

#84 in San Diego, CA

#1,156 in California

#4,918 in US

#10,029 in the World

San Diego, CA (US)
San Diego, CA, United States of America
Forward Citations = 5,902

5 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Prognosys Biosciences, Inc.. Retrieved from https://idiyas.com/company/prognosys-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…